Trials / Unknown
UnknownNCT06089642
Virtual Reality Therapy for Pain Management at the Emergency Department
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 16 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Rationale: Prescriptions of analgesics, especially opioids, have doubled in the Emergency department (ED) over the past decades in response to frequently reported undertreatment of pain in ED patients. Consequently, there is a shift towards a more restrained utilisation of opioids at the ED. However, there are still few (non-)pharmacological alternatives. Virtual Reality (VR) therapy is a relatively new and promising technique in non-pharmacologic pain reduction and anxiolysis and shows positive results on pain relief and pain. Objective: Primary objective is to investigate the effect of VR on patient-reported pain outcomes in the ED. Secondary objectives are to investigate the effect of VR on analgesics use, patient-reported outcomes, and process indicators and to identify barriers to implementation. Last, subanalyses will be performed to compare the effectiveness of two types of VR: VR based on distraction (VRD) and VR based on focussed attention (VRF). Study design: randomized controlled trial. Study population: Adults admitted to the ED with a NRS pain score of 4 (out of ten) or more and unacceptable pain. Intervention: There will be a control group receiving usual care and a intervention group that receives additional VR therapy. Main study parameters/endpoints: The main study outcome is the difference in patient-reported NRS pain score.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual reality | Virtual reality based on distraction and Virtual Reality based on focussed attention |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2023-10-18
- Last updated
- 2024-04-12
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06089642. Inclusion in this directory is not an endorsement.